Arcadia Biosciences Inc. (RKDA)
NASDAQ: RKDA
· Real-Time Price · USD
4.96
0.17 (3.55%)
At close: Jun 06, 2025, 3:57 PM
4.96
0.00%
After-hours: Jun 06, 2025, 04:00 PM EDT
3.55% (1D)
| Bid | 4.91 |
| Market Cap | 6.77M |
| Revenue (ttm) | 5.26M |
| Net Income (ttm) | -2.02M |
| EPS (ttm) | -0.57 |
| PE Ratio (ttm) | -8.69 |
| Forward PE | -1.97 |
| Analyst | Buy |
| Ask | 5.01 |
| Volume | 77,719 |
| Avg. Volume (20D) | 10,350 |
| Open | 4.80 |
| Previous Close | 4.79 |
| Day's Range | 4.90 - 5.08 |
| 52-Week Range | 2.40 - 10.31 |
| Beta | 0.52 |
About RKDA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RKDA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RKDA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
+101.85%
Arcadia Biosciences shares are trading higher afte...
Unlock content with
Pro Subscription
6 months ago
-7.88%
Arcadia Biosciences shares are trading lower. The stock may be moving on continued weakness following a Q3 earnings miss reported on Tuesday.
3 weeks ago · seekingalpha.com
Arcadia Biosciences, Inc. (RKDA) Q1 2025 Earnings Call TranscriptArcadia Biosciences, Inc. (NASDAQ:RKDA ) Q1 2025 Earnings Conference Call May 8, 2025 2:00 PM ET Company Participants Mark Kawakami - Chief Financial Officer T.J. Schaefer - President and Chief Execut...
2 months ago · seekingalpha.com
Arcadia Biosciences, Inc (RKDA) Q4 2024 Earnings Call TranscriptArcadia Biosciences, Inc (NASDAQ:RKDA ) Q4 2024 Results Conference Call March 20, 2025 4:30 PM ET Company Participants Mark Kawakami - Chief Financial Officer T.J. Schaefer - President & Chief Executi...
